{"id":"W2977980618","doi":"10.1097/01.hs9.0000563228.79887.e0","title":"PS1237 DOSE DENSE ABVD (DD‐ABVD) AS FIRST LINE THERAPY IN EARLY‐STAGE UNFAVOURABLE HODGKIN LYMPHOMA (CHL): RESULTS OF A PHASE II, PROSPECTIVE, MULTI‐CENTER STUDY BY FONDAZIONE ITALIANA LINFOMI","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Interim analysis; Vinblastine; Radiation therapy; Prospective cohort study; Surgery; Internal medicine; Nuclear medicine; Clinical trial; Chemotherapy; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001856148,0.0007616114,0.001266422,0.0004176799,0.0002388107,0.0005501204,0.0005138483,0.0005561808,0.001223883],"category_scores_gemma":[0.0008961295,0.0003166119,0.0006947245,0.000424538,0.000656958,0.000467999,0.0002557125,0.001447817,0.0002654246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004588444,"about_ca_system_score_gemma":0.0007312085,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005770554,"about_ca_topic_score_gemma":0.0009449809,"domain_scores_codex":[0.9995042,0.0003231951,0.00002248175,0.00004999053,0.00003979382,0.00006025783],"domain_scores_gemma":[0.9992523,0.0002346647,0.00013399,0.00007491264,0.00003640187,0.0002676372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5634599,0.1110211,0.03631045,0.001083293,0.001901569,0.0003387132,0.0006148373,0.005227417,0.05911352,0.0002880066,0.002278836,0.2183624],"study_design_scores_gemma":[0.2377587,0.7215738,0.03224421,0.00004843174,0.0006659523,0.0003975155,0.00006972002,0.001265867,0.003971904,0.0001389084,0.001839178,0.00002587101],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972219,0.001564281,0.0002665783,0.00008362884,0.00002303356,0.0003313419,0.0001634314,0.00001952725,0.0003261548],"genre_scores_gemma":[0.9961858,0.001331124,0.0007508256,0.0002066173,0.00006759461,0.0004697588,0.0006511548,0.00001159277,0.0003254719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001856148,"threshold_uncertainty_score":0.009816349,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01901969089911033,"score_gpt":0.3009490587376345,"score_spread":0.2819293678385242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}